Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDP Canada NewsWire TORONTO, le 6...
Canadian Investment Regulatory Organization Trading Halt - MDP Canada NewsWire TORONTO, June 6, 2024 TORONTO, June 6, 2024 /CNW/ - The following...
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MDP Canada NewsWire TORONTO, le 6...
Canadian Investment Regulatory Organization Trade Resumption - MDP Canada NewsWire TORONTO, June 6, 2024 TORONTO, June 6, 2024 /CNW/ - Trading...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDP.DB Canada NewsWire TORONTO, le 16...
Canadian Investment Regulatory Organization Trading Halt - MDP.DB Canada NewsWire TORONTO, Oct. 16, 2023 TORONTO, Oct. 16, 2023 /CNW/ - The...
TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the...
TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is...
TORONTO and CHICAGO, April 11, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is...
TORONTO and CHICAGO, March 22, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is...
TORONTO and CHICAGO, March 08, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; TSX: MDP.DB;...
TORONTO and CHICAGO, March 06, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is...
Suspension de la négociation par l'OCRCVM - MDP.WT Canada NewsWire TORONTO, le 23 févr. 2023 TORONTO, le 23 févr. 2023 /CNW/...
IIROC Trading Halt - MDP.WT Canada NewsWire TORONTO, Feb. 23, 2023 TORONTO, Feb. 23, 2023 /CNW/ - The following issues have been halted by...
Results reflect growth across all leading prescription products, demonstrating continued track record of strong...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads